The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Electronic Brachytherapy for the Treatment of NMSC
Official Title: Xoft Electronic Brachytherapy Clinical Protocol For The Primary Treatment Of Non-Melanoma Skin Cancer
Study ID: NCT01016899
Brief Summary: The objective of this study is to record recurrence in patients treated for nonmelanoma (basal cell and squamous cell carcinomas) skin cancer using the Xoft Axxent Electronic Brachytherapy System. Additional objectives include evaluate the appearance of the treated area in patients treated for nonmelanoma skin cancer using the Xoft Axxent Electronic Brachytherapy System and record the occurrence of radiation therapy related skin changes in patients treated for nonmelanoma skin cancer.
Detailed Description: The objective of this study is to record local recurrence in patients treated for nonmelanoma (basal cell and squamous cell carcinomas) skin cancer using the Xoft Axxent Electronic Brachytherapy System. Additional objectives include evaluate the cosmetic outcomes in patients treated for nonmelanoma skin cancer using the Xoft Axxent Electronic Brachytherapy System and record the occurrence of radiation therapy related skin toxicities in patients treated for nonmelanoma skin cancer using the Xoft Axxent Electronic Brachytherapy System.
Minimum Age: 50 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
DCH Cancer Center, Tuscaloosa, Alabama, United States
Cancer Treatment Services - AZ, Casa Grande, Arizona, United States
Southwest Oncology Centers, Scottsdale, Arizona, United States
Diablo Valley Oncology and Hematology Medical Group, Pleasant Hill, California, United States
Parkridge Medical Center - Sara Cannon Cancer Center, Chattanooga, Tennessee, United States
Name: Ajay Bhatnagar, MD, MBA
Affiliation: Cancer Treatment Services-AZ
Role: PRINCIPAL_INVESTIGATOR